Ligand validation:6GD9

EVB: sulfonato-calix[8]arene

EVB is a Ligand Of Interest in 6GD9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GD9_EVB_A_202	93%	25%	0.077	0.971	2.21	0.9	8	4	2	0	100%	1
6GD9_EVB_A_203	92%	24%	0.078	0.969	2.21	0.91	8	3	4	0	100%	1
6GD9_EVB_A_204	8%	24%	0.25	0.723	2.26	0.91	8	2	2	0	100%	1
6GD8_EVB_A_203	100%	22%	0.028	0.995	2.25	1.04	8	10	2	0	100%	1
6Y0J_EVB_B_204	100%	24%	0.045	0.99	2.24	0.91	8	7	0	0	100%	1
6GD7_EVB_A_202	96%	24%	0.065	0.975	2	1.11	8	10	2	0	100%	1
6RSK_EVB_A_202	94%	27%	0.07	0.967	2.07	0.93	28	5	0	0	100%	1
6GDA_EVB_A_203	93%	25%	0.078	0.971	2.21	0.88	8	2	4	0	100%	1
7ALF_EVB_A_101	100%	94%	0.045	0.987	0.25	0.2	-	-	0	0	100%	1
6Z5Q_EVB_B_101	99%	94%	0.053	0.987	0.24	0.19	-	-	0	0	100%	1
7ALG_EVB_B_101	99%	94%	0.055	0.986	0.26	0.18	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.